Corvus Pharmaceuticals (CRVS) Shares Outstanding (Diluted) (2016 - 2026)

Corvus Pharmaceuticals (CRVS) Shares Outstanding (Diluted) (2016 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Outstanding (Dil.) (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn 255.20 Mn
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn 106.00 Mn
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn 64.41 Mn
4 Revolution Medicines 43.64 Bn 43.64 Bn - 210.89 Mn
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn 1.51 Bn
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn 25.05 Bn
7 Royalty Pharma 33.72 Bn 35.84 Bn - 556.90 Mn
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn 138.28 Mn
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn 217.35 Mn
10 Corvus Pharmaceuticals 1.25 Bn 1.04 Bn - 92.37 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 92.37 Mn
Mar 31, 2026 90.00 Mn
Dec 31, 2025 79.74 Mn
Sep 30, 2025 82.84 Mn
Jun 30, 2025 77.77 Mn
Mar 31, 2025 75.15 Mn
Dec 31, 2024 60.99 Mn
Sep 30, 2024 66.70 Mn
Jun 30, 2024 59.71 Mn
Mar 31, 2024 49.04 Mn
Dec 31, 2023 48.03 Mn
Sep 30, 2023 48.97 Mn
Jun 30, 2023 47.50 Mn
Mar 31, 2023 46.56 Mn
Dec 31, 2022 46.55 Mn
Sep 30, 2022 46.55 Mn
Jun 30, 2022 46.55 Mn
Mar 31, 2022 46.55 Mn
Dec 31, 2021 41.85 Mn
Sep 30, 2021 43.95 Mn